Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan’s OTC Drug Makers Devise Backup For Looming On-Line Sales Ban

This article was originally published in PharmAsia News

Executive Summary

Japanese drug makers that specialize in over-the-counter products have devised a new delivery service they hope to use to get around government proposals to ban on-line sales. The Home Medicine Association of Japan would allow buyers to order the same type of drugs and pick them up within three days at nearby stores or pharmacies. Japan's Health Ministry is drafting plans to bar certain OTC drug sales that are not conducted face-to-face with customers. The legislation is required to conform to a pharmaceutical law revision set to take effect in June. Under the new rules, the $276 million on-line drug sales business would be confined to vitamins, intestinal remedies and similar treatments that do not have potentially dangerous side effects. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts